Skip to content

Clinical trials

Phase 1/2 Wilms Tumor trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Wilms Tumor Phase: Phase 1/2 Country / region: United States Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20031
20081
20131
20161
20172
20212
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting3
Terminated3
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center2
Ann & Robert H Lurie Children's Hospital of Chicago1
Children's Oncology Group1
City of Hope Medical Center1
Dana-Farber Cancer Institute1
Duke University1
Hoffmann-La Roche1
Memorial Sloan Kettering Cancer Center1
Sellas Life Sciences Group1
St. Jude Children's Research Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Wilms Tumor13
Neuroblastoma8
Sarcoma8
Kidney Neoplasms6
Ovarian Neoplasms6
Sarcoma, Ewing6
Osteosarcoma5
Carcinoma, Renal Cell4
Neuroectodermal Tumors, Primitive, Peripheral4
Recurrence4

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.